Total Payments
$6,854
2024 Payments
$2,267
Companies
51
Transactions
336
Medicare Patients
630
Medicare Billing
$36,294
Payment Breakdown by Category
Food & Beverage$6,562 (95.7%)
Education$292.48 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,562 | 332 | 95.7% |
| Education | $292.48 | 4 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $543.36 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $540.64 | 20 | $0 (2024) |
| Celgene Corporation | $432.65 | 26 | $0 (2024) |
| Seagen Inc. | $385.80 | 15 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $378.49 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $366.16 | 24 | $0 (2024) |
| Amgen Inc. | $284.00 | 16 | $0 (2023) |
| Genentech USA, Inc. | $280.36 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $260.88 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $254.89 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,267 | 102 | Janssen Biotech, Inc. ($177.85) |
| 2023 | $2,020 | 96 | Novartis Pharmaceuticals Corporation ($314.08) |
| 2022 | $1,822 | 95 | Seagen Inc. ($252.25) |
| 2021 | $745.57 | 43 | Celgene Corporation ($108.69) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 12/17/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/16/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/02/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/22/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: NONE | ||||||
| 11/21/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.76 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Oncology | ||||||
| 11/04/2024 | PFIZER INC. | IBRANCE (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $20.21 | General |
| 10/18/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | AKEEGA (Drug), RYBREVANT | Food and Beverage | In-kind items and services | $93.56 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $36.72 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 117 | 128 | $35,970 | $6,899 |
| 2022 | 2 | 191 | 220 | $35,220 | $10,487 |
| 2021 | 3 | 243 | 301 | $53,715 | $14,881 |
| 2020 | 2 | 79 | 103 | $15,765 | $4,028 |
Total Patients
630
Total Services
752
Medicare Billing
$36,294
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 47 | 52 | $15,860 | $3,121 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 51 | $14,895 | $2,933 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $5,215 | $844.20 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 92 | $17,940 | $5,535 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 128 | $17,280 | $4,952 | 28.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 32 | 42 | $11,130 | $3,892 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 54 | 57 | $11,115 | $3,461 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 70 | $13,650 | $3,138 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 88 | $11,880 | $2,600 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 44 | 44 | $5,940 | $1,790 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 72 | $9,720 | $2,421 | 24.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 31 | $6,045 | $1,607 | 26.6% |
About Christopher Yandell, FNP-BC
Christopher Yandell, FNP-BC is a Family healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1134732738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Yandell, FNP-BC has received a total of $6,854 in payments from pharmaceutical and medical device companies, with $2,267 received in 2024. These payments were reported across 336 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($6,562).
As a Medicare-enrolled provider, Yandell has provided services to 630 Medicare beneficiaries, totaling 752 services with total Medicare billing of $36,294. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Knoxville, TN
- Active Since 08/25/2020
- Last Updated 09/28/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1134732738
Products in Payments
- LIBTAYO (Biological) $397.86
- REBLOZYL (Biological) $289.68
- OPDIVO (Biological) $281.78
- KISQALI (Drug) $227.33
- VERZENIO (Drug) $227.00
- LUMAKRAS (Drug) $174.18
- NINLARO (Drug) $155.89
- RYBREVANT (Drug) $153.88
- ADCETRIS (Biological) $142.81
- DARZALEX (Biological) $142.60
- IMBRUVICA (Drug) $133.24
- VENCLEXTA (Drug) $127.98
- KEYTRUDA (Biological) $125.70
- TUKYSA (Drug) $121.94
- SCEMBLIX (Drug) $117.51
- ULTOMIRIS (Biological) $113.93
- TAGRISSO (Drug) $100.45
- Enhertu (Drug) $98.76
- ERLEADA (Drug) $95.47
- INJECTAFER (Drug) $94.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Knoxville
Karen Roden, Fnp, FNP
Family — Payments: $196,458
Family $196,458
Mrs. Tiffany Sipe, Fnp-Bc, FNP-BC
Family — Payments: $77,018
Family $77,018
Mrs. Ashley Bonnell, Fn-P, FN-P
Family — Payments: $40,051
Family $40,051
Stacey Maltman, Fnp-Bc, FNP-BC
Family — Payments: $21,528
Family $21,528
Mrs. Mina Farrar, Np, NP
Family — Payments: $19,391
Family $19,391
Ashley Bell, Fnp, FNP
Family — Payments: $17,618
Family $17,618